Literature DB >> 26444442

Assessing Toxicity of Intravenous Crystalloids in Critically Ill Patients.

John A Kellum1, Andrew D Shaw2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26444442     DOI： 10.1001/jama.2015.12390

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  The good receipt for the kidneys: salty…but not too much.

Authors:  Stefano Romagnoli; Zaccaria Ricci
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

Review 2.  0.9% NaCl (Normal Saline) - Perhaps not so normal after all?

Authors:  Neil Blumberg; Jill M Cholette; Anthony P Pietropaoli; Richard Phipps; Sherry L Spinelli; Michael P Eaton; Suzie A Noronha; Jerard Seghatchian; Joanna M Heal; Majed A Refaai
Journal:  Transfus Apher Sci       Date:  2018-02-21       Impact factor: 1.764

Review 3.  Choice of Fluid Therapy in the Initial Management of Sepsis, Severe Sepsis, and Septic Shock.

Authors:  Ronald Chang; John B Holcomb
Journal:  Shock       Date:  2016-07       Impact factor: 3.454

Review 4.  Incorporating Dynamic Assessment of Fluid Responsiveness Into Goal-Directed Therapy: A Systematic Review and Meta-Analysis.

Authors:  Joseph M Bednarczyk; Jason A Fridfinnson; Anand Kumar; Laurie Blanchard; Rasheda Rabbani; Dean Bell; Duane Funk; Alexis F Turgeon; Ahmed M Abou-Setta; Ryan Zarychanski
Journal:  Crit Care Med       Date:  2017-09       Impact factor: 7.598

5.  Assessment of renal hemodynamic toxicity of fluid challenge with 0.9% NaCl compared to balanced crystalloid (PlasmaLyte®) in a rat model with severe sepsis.

Authors:  Pierre-Yves Olivier; François Beloncle; Valérie Seegers; Maher Tabka; Mathilde Renou de La Bourdonnaye; Alain Mercat; Paul Cales; Daniel Henrion; Peter Radermacher; Lise Piquilloud; Nicolas Lerolle; Pierre Asfar
Journal:  Ann Intensive Care       Date:  2017-06-14       Impact factor: 6.925

Review 6.  Intravenous fluids: balancing solutions.

Authors:  Ewout J Hoorn
Journal:  J Nephrol       Date:  2016-11-29       Impact factor: 3.902
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.